Log in
NASDAQ:AMGN

Amgen Stock Forecast, Price & News

$227.16
-0.82 (-0.36 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$226.30
Now: $227.16
$230.07
50-Day Range
$227.98
MA: $243.46
$257.67
52-Week Range
$177.05
Now: $227.16
$264.97
Volume2.10 million shs
Average Volume2.65 million shs
Market Capitalization$133.05 billion
P/E Ratio18.56
Dividend Yield2.80%
Beta0.81
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; Adaptive Biotechnologies; and Eli Lilly and Company. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Read More
Amgen logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 3.0Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.32 out of 5 stars

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryBiotechnology
SectorMedical
Current SymbolNASDAQ:AMGN
CUSIP03116210
Phone805-447-1000
Employees23,400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$23.36 billion
Cash Flow$18.76 per share
Book Value$16.28 per share

Profitability

Net Income$7.84 billion

Miscellaneous

Market Cap$133.05 billion
Next Earnings Date10/28/2020 (Confirmed)
OptionableOptionable
$227.16
-0.82 (-0.36 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMGN News and Ratings via Email

Sign-up to receive the latest news and ratings for AMGN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Amgen (NASDAQ:AMGN) Frequently Asked Questions

How has Amgen's stock price been impacted by Coronavirus (COVID-19)?

Amgen's stock was trading at $198.65 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AMGN stock has increased by 14.4% and is now trading at $227.16.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Amgen?

28 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amgen in the last year. There are currently 1 sell rating, 13 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Amgen
.

When is Amgen's next earnings date?

Amgen is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Amgen
.

How can I listen to Amgen's earnings call?

Amgen will be holding an earnings conference call on Wednesday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Amgen's earnings last quarter?

Amgen Inc. (NASDAQ:AMGN) posted its quarterly earnings results on Tuesday, July, 28th. The medical research company reported $4.25 EPS for the quarter, beating analysts' consensus estimates of $3.81 by $0.44. The medical research company earned $6.21 billion during the quarter, compared to analysts' expectations of $6.19 billion. Amgen had a net margin of 30.04% and a return on equity of 91.98%. Amgen's revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the firm earned $3.97 EPS.
View Amgen's earnings history
.

How often does Amgen pay dividends? What is the dividend yield for Amgen?

Amgen declared a quarterly dividend on Wednesday, October 21st. Investors of record on Monday, November 16th will be paid a dividend of $1.60 per share on Tuesday, December 8th. This represents a $6.40 dividend on an annualized basis and a yield of 2.82%. The ex-dividend date is Friday, November 13th.
View Amgen's dividend history
.

What guidance has Amgen issued on next quarter's earnings?

Amgen updated its FY20 earnings guidance on Tuesday, July, 28th. The company provided earnings per share (EPS) guidance of $15.10-15.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $15.63. The company issued revenue guidance of $25.0-25.6 billion, compared to the consensus revenue estimate of $25.38 billion.

What price target have analysts set for AMGN?

28 brokers have issued 12 month target prices for Amgen's stock. Their forecasts range from $185.00 to $300.00. On average, they anticipate Amgen's stock price to reach $255.48 in the next twelve months. This suggests a possible upside of 12.5% from the stock's current price.
View analysts' price targets for Amgen
.

Who are some of Amgen's key competitors?

What other stocks do shareholders of Amgen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amgen investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Intel (INTC), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV), The Walt Disney (DIS), AT&T (T), Alibaba Group (BABA) and Home Depot (HD).

Who are Amgen's key executives?

Amgen's management team includes the following people:
  • Mr. Robert A. Bradway, Chairman, CEO & Pres (Age 57, Pay $5.61M)
  • Mr. Jonathan P. Graham, Exec. VP, Gen. Counsel & Sec. (Age 59, Pay $2.44M)
  • Dr. David M. Reese M.D., Exec. VP of R&D (Age 57, Pay $2.54M)
  • Mr. Murdo Gordon, Exec. VP of Global Commercial Operations (Age 53, Pay $2.66M)
  • Mr. Peter H. Griffith, Exec. VP & CFO (Age 61)

What is Amgen's stock symbol?

Amgen trades on the NASDAQ under the ticker symbol "AMGN."

Who are Amgen's major shareholders?

Amgen's stock is owned by a variety of retail and institutional investors. Top institutional investors include LSV Asset Management (0.47%), Candriam Luxembourg S.C.A. (0.22%), Envestnet Asset Management Inc. (0.09%), Bartlett & Co. LLC (0.07%), Nisa Investment Advisors LLC (0.05%) and Retirement Systems of Alabama (0.04%). Company insiders that own Amgen stock include Cynthia M Patton, David Piacquad, David W Meline, Jonathan P Graham, R Sanders Williams, Ronald D Sugar and Tyler Jacks.
View institutional ownership trends for Amgen
.

Which major investors are selling Amgen stock?

AMGN stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, Cardinal Capital Management Inc., Wedge Capital Management L L P NC, Standard Life Aberdeen plc, DNB Asset Management AS, Redpoint Investment Management Pty Ltd, Pacer Advisors Inc., and Retirement Systems of Alabama. Company insiders that have sold Amgen company stock in the last year include David Piacquad, David W Meline, Jonathan P Graham, R Sanders Williams, and Ronald D Sugar.
View insider buying and selling activity for Amgen
.

Which major investors are buying Amgen stock?

AMGN stock was acquired by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., Boston Trust Walden Corp, State of Alaska Department of Revenue, Contravisory Investment Management Inc., USA Financial Portformulas Corp, CHURCHILL MANAGEMENT Corp, Avantax Advisory Services Inc., and Hall Laurie J Trustee.
View insider buying and selling activity for Amgen
.

How do I buy shares of Amgen?

Shares of AMGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Amgen's stock price today?

One share of AMGN stock can currently be purchased for approximately $227.16.

How big of a company is Amgen?

Amgen has a market capitalization of $133.05 billion and generates $23.36 billion in revenue each year. The medical research company earns $7.84 billion in net income (profit) each year or $14.82 on an earnings per share basis. Amgen employs 23,400 workers across the globe.

What is Amgen's official website?

The official website for Amgen is www.amgen.com.

How can I contact Amgen?

Amgen's mailing address is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. The medical research company can be reached via phone at 805-447-1000 or via email at [email protected]

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.